4-butyrolactone has been researched along with Lung Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doroques, DB; Frank, DW; Gropper, MA; Kurahashi, K; Long, T; Ohara, M; Sawa, T; Twining, SS; Wiener-Kronish, JP | 1 |
| Eberl, L; Geisenberger, O; Givskov, M; Høiby, N; Riedel, K; Tümmler, B | 1 |
2 other study(ies) available for 4-butyrolactone and Lung Diseases
| Article | Year |
|---|---|
In vitro cellular toxicity predicts Pseudomonas aeruginosa virulence in lung infections.
Topics: 4-Butyrolactone; Animals; Cell Line; Endopeptidases; Homoserine; Humans; Lung; Lung Diseases; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Virulence | 1998 |
Production of N-acyl-L-homoserine lactones by P. aeruginosa isolates from chronic lung infections associated with cystic fibrosis.
Topics: 4-Butyrolactone; Burkholderia cepacia; Burkholderia Infections; Chromatography, Thin Layer; Chronic Disease; Cystic Fibrosis; Gene Expression Regulation, Bacterial; Humans; Lung Diseases; Pseudomonas aeruginosa; Pseudomonas Infections; Signal Transduction | 2000 |